SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 15,592.80 |
Enterprise Value ($M) | 24,895.59 |
Book Value ($M) | 9,525.37 |
Book Value / Share | 21.49 |
Price / Book | 1.64 |
NCAV ($M) | -4,733.19 |
NCAV / Share | -10.68 |
Price / NCAV | -3.29 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.00 |
Return on Assets (ROA) | 0.00 |
Return on Equity (ROE) | 0.00 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.19 |
Current Ratio | 2.19 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 2,554.91 |
Assets | 16,813.47 |
Liabilities | 7,288.09 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 2,237.00 |
Operating Income | 923.00 |
Net Income | 43.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 2,144.00 |
Cash from Investing | -1,029.00 |
Cash from Financing | -945.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | General Atlantic Llc | 5.60 | 0.00 | |
13G/A | Morgan Stanley | 9.90 | -21.85 | |
13G/A | Adage Capital Partners Gp, L.l.c. | 1.59 | -71.82 | |
13G/A | Fmr Llc | 10.00 | 99.78 | |
13G/A | Vanguard Group Inc | 8.08 | 20.22 | |
13D/A | Giuliani Mario Germano | 10.00 | -5.40 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
204,246 | 1,378,976 | 14.81 | |
297,065 | 1,912,847 | 15.53 | |
428,396 | 2,389,440 | 17.93 | |
254,779 | 2,233,628 | 11.41 | |
(click for more detail) |
Similar Companies | |
---|---|
RNXT – RenovoRx, Inc. | ROIV – Roivant Sciences Ltd |
RPHM – Reneo Pharmaceuticals, Inc. | RPTX – Repare Therapeutics Inc |
RTVA – Artiva Biotherapeutics Inc |
Financial data and stock pages provided by
Fintel.io